From January to October, the total output of lithium batteries in China increased by 16% year-on-year. According to the Ministry of Industry and Information Technology, China's lithium-ion battery industry continued to grow from January to October 2024. According to the announcement of lithium battery industry norms, enterprise information and industry associations, the total output of lithium batteries in China from January to October was 890GWh, up 16% year-on-year. According to the data of the National Bureau of Statistics, the profit of China's lithium battery manufacturing industry increased by 39.4% from January to October. In the battery sector, the output of energy storage lithium batteries exceeded 200GWh from January to October. The loading capacity of power lithium batteries for new energy vehicles is about 405GWh. From January to October, the total export of lithium batteries in China reached 350.2 billion yuan, down 9.2% year-on-year, and the decline was 3.3 percentage points narrower than that in January-June.China Merchants Securities: Investment Guidelines of the Central Economic Work Conference for A-shares next year From these four aspects, China Merchants Securities said that the investment guidelines of the Central Economic Work Conference for A-shares next year mainly include the following aspects: 1) From a macro perspective, the support intensity of policies for various economic work is expected to exceed market expectations. Specifically, the fiscal policy orientation is positive, deficit ratio will arrange or keep it above 3%, the issuance scale of ultra-long-term special government bonds will be further expanded, and the scale and investment field of special bonds are expected to be further extended; Monetary policy mentioned "timely lowering the RRR and cutting interest rates", and the goal of liquidity policy changed from balance to loose tendency, which will bring room for valuation improvement of A shares. 2) From the perspective of expanding domestic demand, consumption will become the main line of investment next year: the meeting will continue the deployment of the Politburo meeting in December, and in the order of writing, consumption will still be placed at the top of next year's key tasks. In terms of specific measures, it is planned to boost consumption mainly through two aspects. First, increase the income of residents; The second is to increase consumption scenarios. 3) Focus on scientific and technological innovation to lead the development of new quality productive forces, and grasp two main lines: this meeting focused on "carrying out' artificial intelligence+'action and cultivating future industries". Artificial intelligence has appeared in the draft of the Central Economic Work Conference for three consecutive years. Future industries have also appeared in the draft of the Central Economic Work Conference for two consecutive years. Therefore, it is recommended to focus on artificial intelligence+and future industries. 4) Focus on "comprehensive improvement of' involution' competition": In terms of "involution" competition, photovoltaic industry is the representative in emerging industries. Recently, in addition to self-regulatory measures such as industry association initiatives, the photovoltaic export tax rebate rate has been lowered and industry norms have been updated to further control new production capacity. The policy is further introduced to curb the "involution" competition of photovoltaics. It is recommended to pay attention to photovoltaic, lithium battery and other industries.Internal notice of Extreme Vietnam: The social security accumulation fund has been paid successfully in November, and the company's financial status may not be paid normally in December. According to the internal staff of Extreme Vietnam, the internal notice issued by Extreme Vietnam said that the social security accumulation fund and individual tax in Shanghai, Beijing and Zhejiang, which everyone is concerned about at present, have just been paid successfully thanks to the strong support of shareholders of Baidu and Geely. Please believe that the company is doing its best to tide over the difficulties with you. However, the notice also mentioned, "We are still very sorry about the problem in December. The company's book cash has bottomed out, and according to the relevant regulations of social security, December 13 is the final time limit for operating social security downsizing. If you miss the window period, the social security accumulation fund in December will not be paid in your own name. Colleagues who choose not to downsize may face the same problem next month. "(Sina Technology)
[The yield of 30-year treasury bonds fell below the 2% mark, and the active bonds of 30-year treasury bonds fell below 2% by 4.26bp, reaching 1.9999% as of press time.Meijin Energy has set up a new coal washing company with 100 million yuan. According to the enterprise investigation APP, Shanxi Meijin Taiyue Coal Washing Co., Ltd. was recently established, with Wu Yong as the legal representative and a registered capital of 100 million yuan. Its business scope includes: coal washing; Sales of coal and products; Coal-based activated carbon and other coal processing. Enterprise investigation shows that the company is wholly owned by Meijin Energy.The merger of Guotai Junan Haitong Securities was approved by the shareholders' meeting, and the merger and reorganization of Guotai Junan and Haitong Securities completed a key step. On the evening of December 13, the two companies simultaneously announced the resolutions of the shareholders' meeting. The merger and reorganization transaction plan and other related proposals were reviewed by the shareholders' meeting and passed by high votes. The merger and reorganization of Guotai Junan and Haitong Securities is the first merger and reorganization of head brokers since the implementation of the new "National Nine Articles". It is also the largest A+H bilateral market merger and the largest integration case of listed brokers in the history of China capital market, and the largest M&A project in international investment banking since 2008, involving multi-business licenses and a number of domestic and foreign listed subsidiaries.
On the 13th, the No.20 rubber fell by 2.05%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract No.20 rubber 2502 was closed, with a turnover of 159,100 lots. The position data showed that the top 20 seats were clear, and the difference position was 5,142 lots. A total of 205,200 lots were traded in the No.20 rubber futures contract, an increase of 8,176 lots over the previous day. The first 20 seats in the contract held 84,200 lots, an increase of 812 lots over the previous day. Short positions in the top 20 seats of the contract were 94,500 lots, a decrease of 1,708 lots from the previous day. (Sina Futures)On the 13th, SSE 50 index futures fell by 2.58%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, SSE 50 index futures closed at 2,412, up or down by -2.58%, with a turnover of 53,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7,398 lots. The total number of contracts of SSE 50 index futures was 91,500 lots, an increase of 25,700 lots over the previous day. The first 20 seats in the contract held 88,200 lots, an increase of 2,257 lots over the previous day. The short positions in the top 20 seats of the contract were 113,700 lots, an increase of 1,701 lots over the previous day. (Sina Futures)Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14